Genmab A (GMAB) Current Deferred Revenue (2023 - 2026)
Genmab A's Current Deferred Revenue was $88 million in the quarter ended Jun 30, 2026, unchanged from the prior quarter.
Powered by 
Analysis
Genmab A (GMAB) Current Deferred Revenue (2023 - 2026) Analysis & Trends
As of Dec 31, 2025, Current Deferred Revenue at Genmab A came in at $95 million, up 41.8% from the prior year.
- Current Deferred Revenue shows a five-year compound annual growth rate of 10.9% (years ended Dec 2020 to Dec 2025).
- In earlier years, Current Deferred Revenue was $67 million in the year ended Dec 31, 2024 (-5.6%), $71 million in the year ended Dec 31, 2023 (+58.5%), $44.79 million in the year ended Dec 31, 2022 (-18.6%) and $55.03 million in the year ended Dec 31, 2021 (-2.7%).
- Quarterly Current Deferred Revenue has moved between $44.45 million (the quarter ended Sep 30, 2023) and $95 million (the quarter ended Dec 31, 2025) over five years.
- Compared with a year earlier, Current Deferred Revenue was higher in three of the last four quarters, with growth averaging 52.7%.
- The best year-over-year quarter for Current Deferred Revenue over five years was the quarter ended Dec 31, 2025 (growth of 112.7%); the worst was the quarter ended Sep 30, 2021 (a decline of 99.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Genmab A | 2.56 Bn | -2.81 Bn | 1.07 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 88.00 Mn |
| Mar 31, 2026 | 88.00 Mn |
| Dec 31, 2025 | 95.00 Mn |
| Sep 30, 2025 | 67.00 Mn |
| Jun 30, 2025 | 67.00 Mn |
| Mar 31, 2025 | 70.00 Mn |
| Dec 31, 2024 | 67.00 Mn |
| Dec 31, 2023 | 71.00 Mn |
| Jan 1, 2023 | 69.00 Mn |
API Access
Genmab A Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=GMAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "GMAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=GMAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();